2.47
                                            Schlusskurs vom Vortag:
              $2.31
            Offen:
              $2.23
            24-Stunden-Volumen:
                96,706
            Relative Volume:
              1.77
            Marktkapitalisierung:
                $8.48M
            Einnahmen:
              -
            Nettoeinkommen (Verlust:
              $2.81M
            KGV:
              -0.1721
            EPS:
                -14.3497
            Netto-Cashflow:
                $7.14M
            1W Leistung:
              -2.37%
            1M Leistung:
              -10.18%
            6M Leistung:
                -25.49%
            1J Leistung:
              -31.39%
            Kiora Pharmaceuticals Inc Stock (KPRX) Company Profile
Firmenname
                  
                      Kiora Pharmaceuticals Inc
                    
                Sektor
                  Branche
                  Telefon
                  
                      858-224-9600
                    
                Adresse
                  
                      169 SAXONY RD., ENCINITAS
                    
                Vergleichen Sie KPRX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV | 
|---|---|---|---|---|---|---|
| 
                         
                          
                                KPRX
                            
                             
                        Kiora Pharmaceuticals Inc 
                           | 
                    2.47 | 7.93M | 0 | 2.81M | 7.14M | -14.35 | 
| 
                         
                          
                                VRTX
                            
                             
                        Vertex Pharmaceuticals Inc 
                           | 
                    426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 | 
| 
                         
                          
                                REGN
                            
                             
                        Regeneron Pharmaceuticals Inc 
                           | 
                    642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 | 
| 
                         
                          
                                ALNY
                            
                             
                        Alnylam Pharmaceuticals Inc 
                           | 
                    434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 | 
| 
                         
                          
                                ARGX
                            
                             
                        Argen X Se Adr 
                           | 
                    826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 | 
| 
                         
                          
                                INSM
                            
                             
                        Insmed Inc 
                           | 
                    186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 | 
Kiora Pharmaceuticals Inc Aktie (KPRX) Neueste Nachrichten
Can Kiora Pharmaceuticals Inc. (7EY) stock attract ESG investments2025 Key Highlights & Community Verified Trade Alerts - newser.com
News impact scoring models applied to Kiora Pharmaceuticals Inc.Take Profit & Fast Entry High Yield Tips - newser.com
Can Kiora Pharmaceuticals Inc. stock sustain free cash flow growthWeekly Trend Report & Weekly Setup with ROI Potential - newser.com
Analyzing recovery setups for Kiora Pharmaceuticals Inc. investors2025 Analyst Calls & AI Driven Price Predictions - newser.com
Kiora Pharmaceuticals’ KIO-104: A Promising Treatment for Macular Edema? - MSN
Is Kiora Pharmaceuticals Inc. stock supported by strong cash flowsPrice Action & AI Driven Stock Movement Reports - newser.com
Using data filters to optimize entry into Kiora Pharmaceuticals Inc.Quarterly Earnings Summary & Free Accurate Trade Setup Notifications - newser.com
Is it time to cut losses on Kiora Pharmaceuticals Inc.Quarterly Market Review & Stepwise Trade Execution Plans - newser.com
Will Kiora Pharmaceuticals Inc. continue its uptrendJuly 2025 Opening Moves & Consistent Profit Trade Alerts - newser.com
Chart based exit strategy for Kiora Pharmaceuticals Inc.2025 Key Highlights & Capital Protection Trading Alerts - newser.com
Why global investors buy Kiora Pharmaceuticals Inc. (7EY) stockJuly 2025 Momentum & Expert Curated Trade Setup Alerts - newser.com
How buyback programs support Kiora Pharmaceuticals Inc. (7EY) stockCPI Data & Stock Market Timing Techniques - newser.com
Will Kiora Pharmaceuticals Inc. stock benefit from infrastructure spendingJuly 2025 Summary & Scalable Portfolio Growth Methods - newser.com
Will Kiora Pharmaceuticals Inc. (7EY) stock benefit from commodity supercyclePortfolio Value Summary & Daily Volume Surge Signals - newser.com
When is the best time to exit Kiora Pharmaceuticals Inc.July 2025 Gainers & Consistent Growth Equity Picks - newser.com
Intraday pattern recognizer results for Kiora Pharmaceuticals Inc.Bear Alert & AI Enhanced Trade Execution Alerts - newser.com
Can Kiora Pharmaceuticals Inc. rally from current levelsTrade Analysis Report & Expert Curated Trade Setup Alerts - newser.com
Real time breakdown of Kiora Pharmaceuticals Inc. stock performance2025 Dividend Review & Free Daily Entry Point Trade Alerts - newser.com
Can Kiora Pharmaceuticals Inc. stock double in next 5 yearsMarket Growth Report & Technical Analysis for Trade Confirmation - newser.com
Heatmap analysis for Kiora Pharmaceuticals Inc. and competitors2025 Trading Volume Trends & Safe Entry Momentum Stock Tips - newser.com
Tools to monitor Kiora Pharmaceuticals Inc. recovery probability2025 Support & Resistance & Daily Risk Controlled Trade Plans - newser.com
Will Kiora Pharmaceuticals Inc. stock deliver consistent dividends2025 EndofYear Setup & Long Hold Capital Preservation Tips - newser.com
How to track smart money flows in Kiora Pharmaceuticals Inc.July 2025 Sentiment & Risk Controlled Stock Pick Alerts - newser.com
What analysts say about Kiora Pharmaceuticals Inc stockOptions Trading Strategies & Small Entry Investment Ideas - earlytimes.in
Kiora (NASDAQ: KPRX) joins RARE-X Vision Consortium to support rare ocular data sharing - Stock Titan
Finanzdaten der Kiora Pharmaceuticals Inc-Aktie (KPRX)
Umsatz
Nettogewinn
Free Cashflow
ENV
        In Yahoo öffnen
        |
        In Google öffnen
            |
            In Finviz öffnen
        |
        In MarketWatch öffnen
            |
            Öffnen Sie in EDGAR    
        |
        Offen in Reuters
    
    
                Kapitalisierung:
                 
                  | 
                Volumen (24h):